Literature DB >> 31673538

Machine perfusion strategies in liver transplantation.

Andrea Schlegel1,2,3, Xavier Muller3, Philipp Dutkowski3.   

Abstract

Machine perfusion is a hot topic in liver transplantation and several new perfusion concepts are currently developed. Prior to introduction into routine clinical practice, however, such perfusion approaches need to demonstrate their impact on liver function, post-transplant complications, utilization rates of high-risk organs, and cost benefits. Therefore, based on results of experimental and clinical studies, the community has to recognize the limitations of this technology. In this review, we summarize current perfusion concepts and differences between protective mechanisms of ex- and in-situ perfusion techniques. Next, we discuss which graft types may benefit most from perfusion techniques, and highlight the current understanding of liver viability testing. Finally, we present results from recent clinical trials involving machine liver perfusion, and analyze the value of different outcome parameters, currently used as endpoints for randomized controlled trials in the field. 2019 Hepatobiliary Surgery and Nutrition. All rights reserved.

Keywords:  Machine perfusion; clinical trials; viability assessment

Year:  2019        PMID: 31673538      PMCID: PMC6791985          DOI: 10.21037/hbsn.2019.04.04

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN: 2304-3881            Impact factor:   7.293


  88 in total

1.  Alexis Carrel: genius, innovator and ideologist.

Authors:  P Dutkowski; O de Rougemont; P-A Clavien
Journal:  Am J Transplant       Date:  2008-08-22       Impact factor: 8.086

2.  Soluble Adhesion Molecules During Ex Vivo Lung Perfusion Are Associated With Posttransplant Primary Graft Dysfunction.

Authors:  K Hashimoto; M Cypel; H Kim; T N Machuca; D Nakajima; M Chen; M K Hsin; R Zamel; S Azad; T K Waddell; M Liu; S Keshavjee
Journal:  Am J Transplant       Date:  2017-02-01       Impact factor: 8.086

Review 3.  Machine perfusion in liver transplantation: an essential treatment or just an expensive toy?

Authors:  Andrea A Schlegel; Marit Kalisvaart; Paolo Muiesan
Journal:  Minerva Anestesiol       Date:  2017-07-20       Impact factor: 3.051

4.  Reply to: "DCD consensus and futility in liver transplantation".

Authors:  A Schlegel; M Kalisvaart; J Isaac; P Muiesan
Journal:  J Hepatol       Date:  2018-04-13       Impact factor: 25.083

5.  Oxygenated Hypothermic Machine Perfusion After Static Cold Storage Improves Hepatobiliary Function of Extended Criteria Donor Livers.

Authors:  Andrie C Westerkamp; Negin Karimian; Alix P M Matton; Paria Mahboub; Rianne van Rijn; Janneke Wiersema-Buist; Marieke T de Boer; Henri G D Leuvenink; Annette S H Gouw; Ton Lisman; Robert J Porte
Journal:  Transplantation       Date:  2016-04       Impact factor: 4.939

Review 6.  Donor-recipient matching: myths and realities.

Authors:  Javier Briceño; Ruben Ciria; Manuel de la Mata
Journal:  J Hepatol       Date:  2012-10-24       Impact factor: 25.083

7.  The UK DCD Risk Score: A new proposal to define futility in donation-after-circulatory-death liver transplantation.

Authors:  Andrea Schlegel; Marit Kalisvaart; Irene Scalera; Richard W Laing; Hynek Mergental; Darius F Mirza; Thamara Perera; John Isaac; Philipp Dutkowski; Paolo Muiesan
Journal:  J Hepatol       Date:  2017-11-15       Impact factor: 25.083

8.  A preliminary European Liver and Intestine Transplant Association-European Liver Transplant Registry study on informed recipient consent and extended criteria liver donation.

Authors:  P Bruzzone; D Giannarelli; R Adam
Journal:  Transplant Proc       Date:  2013-09       Impact factor: 1.066

9.  Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS.

Authors:  Edward T Chouchani; Victoria R Pell; Edoardo Gaude; Dunja Aksentijević; Stephanie Y Sundier; Ellen L Robb; Angela Logan; Sergiy M Nadtochiy; Emily N J Ord; Anthony C Smith; Filmon Eyassu; Rachel Shirley; Chou-Hui Hu; Anna J Dare; Andrew M James; Sebastian Rogatti; Richard C Hartley; Simon Eaton; Ana S H Costa; Paul S Brookes; Sean M Davidson; Michael R Duchen; Kourosh Saeb-Parsy; Michael J Shattock; Alan J Robinson; Lorraine M Work; Christian Frezza; Thomas Krieg; Michael P Murphy
Journal:  Nature       Date:  2014-11-05       Impact factor: 49.962

10.  Combined Hypothermic and Normothermic Machine Perfusion Improves Functional Recovery of Extended Criteria Donor Livers.

Authors:  Yuri L Boteon; Richard W Laing; Andrea Schlegel; Lorraine Wallace; Amanda Smith; Joseph Attard; Ricky H Bhogal; Desley A H Neil; Stefan Hübscher; M Thamara P R Perera; Darius F Mirza; Simon C Afford; Hynek Mergental
Journal:  Liver Transpl       Date:  2018-12       Impact factor: 5.799

View more
  9 in total

1.  Utilization of dielectric properties for assessment of liver ischemia-reperfusion injury in vivo and during machine perfusion.

Authors:  Jie Hou; Olav Magnus Ivar Liavåg; Ida Høy Færden; Ørjan Grøttem Martinsen; Tor Inge Tønnessen; Pål-Dag Line; Morten Hagness; Jan Olav Høgetveit; Søren Erik Pischke; Runar Strand-Amundsen
Journal:  Sci Rep       Date:  2022-07-01       Impact factor: 4.996

2.  Human liver stem cell-derived extracellular vesicles reduce injury in a model of normothermic machine perfusion of rat livers previously exposed to a prolonged warm ischemia.

Authors:  Nicola De Stefano; Victor Navarro-Tableros; Dorotea Roggio; Alberto Calleri; Federica Rigo; Ezio David; Alessandro Gambella; Daniela Bassino; Antonio Amoroso; Damiano Patrono; Giovanni Camussi; Renato Romagnoli
Journal:  Transpl Int       Date:  2021-09       Impact factor: 3.842

Review 3.  Restoring Mitochondrial Function While Avoiding Redox Stress: The Key to Preventing Ischemia/Reperfusion Injury in Machine Perfused Liver Grafts?

Authors:  Julia Hofmann; Giorgi Otarashvili; Andras Meszaros; Susanne Ebner; Annemarie Weissenbacher; Benno Cardini; Rupert Oberhuber; Thomas Resch; Dietmar Öfner; Stefan Schneeberger; Jakob Troppmair; Theresa Hautz
Journal:  Int J Mol Sci       Date:  2020-04-29       Impact factor: 5.923

4.  Evaluation of Liver Quality after Circulatory Death Versus Brain Death: A Comparative Preclinical Pig Model Study.

Authors:  Jérôme Danion; Raphael Thuillier; Géraldine Allain; Patrick Bruneval; Jacques Tomasi; Michel Pinsard; Thierry Hauet; Thomas Kerforne
Journal:  Int J Mol Sci       Date:  2020-11-27       Impact factor: 5.923

5.  Modular assembly-based approach of loosely packing co-cultured hepatic tissue elements with endothelialization for liver tissue engineering.

Authors:  Jianyu He; Yuan Pang; Huayu Yang; Kevin Montagne; Marie Shinohara; Yilei Mao; Wei Sun; Yasuyuki Sakai
Journal:  Ann Transl Med       Date:  2020-11

Review 6.  Hemorheological and Microcirculatory Factors in Liver Ischemia-Reperfusion Injury-An Update on Pathophysiology, Molecular Mechanisms and Protective Strategies.

Authors:  Norbert Nemeth; Katalin Peto; Zsuzsanna Magyar; Zoltan Klarik; Gabor Varga; Mihai Oltean; Anna Mantas; Zoltan Czigany; Rene H Tolba
Journal:  Int J Mol Sci       Date:  2021-02-13       Impact factor: 5.923

7.  Early Allograft Dysfunction Increases Hospital Associated Costs After Liver Transplantation-A Propensity Score-Matched Analysis.

Authors:  Simon Moosburner; Igor M Sauer; Frank Förster; Thomas Winklmann; Joseph Maria George Vernon Gassner; Paul V Ritschl; Robert Öllinger; Johann Pratschke; Nathanael Raschzok
Journal:  Hepatol Commun       Date:  2020-12-05

8.  Strategies for liver transplantation during the SARS-CoV-2 outbreak: Preliminary experience from a single center in France.

Authors:  Xavier Muller; Gilles Tilmans; Quentin Chenevas-Paule; Fanny Lebossé; Teresa Antonini; Domitille Poinsot; Agnès Rode; Céline Guichon; Zoé Schmitt; Christian Ducerf; Kayvan Mohkam; Mickaël Lesurtel; Jean-Yves Mabrut
Journal:  Am J Transplant       Date:  2020-07-05       Impact factor: 9.369

Review 9.  Preventing Tumour Recurrence after Liver Transplantation: The Role of Machine Perfusion.

Authors:  Yuri Boteon; Mauricio Alfredo Flores Carvalho; Rebecca Panconesi; Paolo Muiesan; Andrea Schlegel
Journal:  Int J Mol Sci       Date:  2020-08-12       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.